SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3561 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
735Tuck, <<A couple of Axokine related news items today, both good if not earMiljenko Zuanic-1/9/2003
734Nice to have fast track status for severe obese population. This was primary tarMiljenko Zuanic-1/7/2003
733A couple of Axokine related news items today, both good if not earth shattering:tuck-1/7/2003
732Sage did started, as expected. Now, the question is how many options did they cMiljenko Zuanic-12/30/2002
731Leonard sells 55,000 shares & Murray another 14,000...mopgcw-12/30/2002
730Feb and May Call/Put ratio is clearly positive. Maybe the shorts have hedged??keokalani'nui-12/26/2002
729Short interest steady at 7.1 M. Dec. 13, 2002 7,160,762 414,946 17.26 Nov. 15, Miljenko Zuanic-12/26/2002
728>>TARRYTOWN, N.Y.--(BUSINESS WIRE)--Dec. 23, 2002-- Regeneron Pharmaceutictuck-12/23/2002
727Abstr now avail on-line: Nat Med 2002 Dec 16; [epub ahead of print] Related Artkeokalani'nui-12/21/2002
726I am not sure what murray's options position is like, but the remaining posimopgcw-12/20/2002
725First Stahl, than Guler, now Murray. I guess this was part of the *planed* sale Miljenko Zuanic-12/20/2002
724Murray Goldberg CFO cashes in 14,000 @20+.mopgcw-12/20/2002
723Very, very strong endorsement of the anti-VEGF therapy for AMD and DME. If I taMiljenko Zuanic-12/20/2002
722Press Release Source: Regeneron Pharmaceuticals Today's News On The Net - BuMiljenko Zuanic-12/19/2002
721jci.org J. Clin. Invest. 110:1619-1628 (2002). doi:10.1172/JCI200215621. CopyriMiljenko Zuanic-12/3/2002
720[Cancer Research 62, 7124-7129, December 1, 2002] © 2002 American AssociatiMiljenko Zuanic-12/2/2002
719Short interest slightly declined. Nov. 15, 2002 7,139,043 265,571 26.88 HappyMiljenko Zuanic-11/27/2002
718Peter, <<In my view most "analysts" are primarily concerned witMiljenko Zuanic-11/25/2002
717Miljenko, <i>Doesn't they have *priority* for fresh results and/or *rBiomaven-11/25/2002
716WE, Not to hype anything, I will said it is power of the media, one way or anothMiljenko Zuanic-11/21/2002
715<or did portfolio managers suddenly wake up and realize that MZ likes this stsmh-11/21/2002
714<Meanwhile, people keep putting on the pounds. Some 31% of the adult populatiElmer-11/21/2002
713Quid As you know, it has been two very good days in a row for BT in general, alkeokalani'nui-11/21/2002
712Wildest, is this all due to the Forbes Article, which didn't seem that over-quidditch-11/21/2002
711Forbes. Forbes Magazine Hunger Pangs Wednesday November 20, 7:28 pm ET By Zinakeokalani'nui-11/20/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News